Suvarna Sharma1 and Sumit Sharma2*
1Postgraduate Second year, Internal Medicine, GSVM Medical College, Kanpur, India
2Professor and Head, Department of ENT, Dr. KNS Memorial Institute of Medical Sciences,
Gadia Barabanki, India
*Corresponding Author: Sumit Sharma, Professor and Head, Department of ENT, Dr. KNS Memorial Institute of Medical Sciences, Gadia Barabanki, India.
Received: November 28, 2024; Published: December 01, 2024
Allergic rhinitis (AR) is a common chronic respiratory condi tion that significantly impacts the quality of life of millions glob ally. Characterized by nasal congestion, sneezing, rhinorrhea, and itching, it is often triggered by allergens such as pollen, dust mites, mold, and animal dander. Though pharmacological treatments such as antihistamines, nasal corticosteroids, and decongestants offer symptomatic relief, they do not address the root cause of the condition. Immunotherapy, specifically allergen immunotherapy (AIT), presents a unique therapeutic approach aimed at modifying the underlying allergic response rather than just managing symp toms. Despite its efficacy, public awareness and adoption remain limited due to a lack of education, misconceptions, and accessibil ity challenges.
Citation: Suvarna Sharma and Sumit Sharma. “Awareness on Immune Therapy for Allergic Rhinitis".Acta Scientific Otolaryngology 7.1 (2025): 01-03.
Copyright: © 2025 Suvarna Sharma and Sumit Sharma. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.